---
layout: post
title: "Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4; Guidance for Industry; Availability"
date: 2026-02-05 18:58:33 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-05776
original_published: 2022-03-23 00:00:00 +0000
significance: 8.00
---

# Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4; Guidance for Industry; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 23, 2022 00:00 UTC
**Document Number:** 2022-05776

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for industry entitled "Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR part 4." This guidance describes FDA's compliance policy with respect to the requirements of FDA regulations that are now applicable to ophthalmic drugs that are packaged with eye cups, eye droppers, and other dispensers intended for ophthalmic use.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/23/2022-05776/certain-ophthalmic-products-policy-regarding-compliance-with-21-cfr-part-4-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2022-05776

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
